Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Dyloject diclofenac sodium: Phase III data

In the double-blind Phase III DFC-004 trial in 331 patients, low and high doses of Dyloject

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE